CementON® Tibial Mold

Efficient and Standardised Procedure for Tibial Cementation


CementON® Tibial Molds are designed with an implant-cement interface enhancement technology that is unique in the joint arthroplasty market. This technology offers a convenient and reproducible method for applying bone cement to implants.

The CementON Molds facilitate early cement application to a tibial tray, which results in an increased implant-cement interface strength. It is designed to eliminate the need to touch the cement and the implant during application, thereby minimising the risk of implant-cement interface contamination and cement exposure to air.1,2

The goal is to establish a strong bond between the implant-cement and cement-bone interfaces.

CementON Tibial Mold features:

  • Facilitates early cement application
  • Eliminates the need to touch the cement and the tibial implant
  • Standardises the tibial tray cementation
  • Offers a convenient and reproducible procedure for bone cement application

Legal Manufacturer:

Biomet Orthopedics
P.O. Box 587
56 E. Bell Drive
Warsaw, Indiana 46581-0587

  1. Kavanaugh A, et al. Factors Influencing the Initial Strength of the Tibial Tray-Cement Interface Bond. Bone Joint J 2013 vol. 95-B no. SUPP 34 98.
  2. Data on file at Zimmer Biomet. Bench test results not necessarily indicative of clinical performance. The file is available upon request.

Related Products

All content herein is protected by copyright, trademarks and other intellectual property rights, as applicable, owned by or licensed to Zimmer Biomet or its affiliates unless otherwise indicated, and must not be redistributed, duplicated or disclosed, in whole or in part, without the express written consent of Zimmer Biomet.  
This material is intended for health care professionals.  Distribution to any other recipient is prohibited.
For product information, including indications, contraindications, warnings, precautions, potential adverse effects and patient counselling information, see the package insert and information on this website. To obtain a copy of the current Instructions for Use (IFU) for full prescribing and risk information, please call 1-800-348-2759, press 4 for 411 Technical Support.